Similarly, p-cresyl sulfate (pCS) disrupts the integrity of the blood-brain barrier via epidermal growth factor receptor (EGFR)/STAT3 signaling, linking gut-derived toxins to cerebrovascular risk in CKD patients (38). Here, EGFR is linked to chronic kidney disease.